A detailed history of Creative Planning transactions in Embecta Corp. stock. As of the latest transaction made, Creative Planning holds 36,302 shares of EMBC stock, worth $514,036. This represents 0.0% of its overall portfolio holdings.

Number of Shares
36,302
Holding current value
$514,036
% of portfolio
0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 15, 2024

BUY
$10.13 - $14.6 $367,739 - $530,009
36,302 New
36,302 $453,000
Q4 2023

Feb 14, 2024

SELL
$12.87 - $19.09 $28,262 - $41,921
-2,196 Reduced 12.65%
15,167 $287,000
Q3 2023

Nov 16, 2023

BUY
$15.0 - $22.17 $260,445 - $384,937
17,363 New
17,363 $261,000
Q1 2023

May 15, 2023

SELL
$23.07 - $32.77 $33,659 - $47,811
-1,459 Reduced 17.01%
7,120 $200,000
Q4 2022

Feb 10, 2023

BUY
$25.29 - $35.48 $35,431 - $49,707
1,401 Added 19.52%
8,579 $216,000
Q3 2022

Nov 03, 2022

BUY
$24.0 - $33.42 $172,272 - $239,888
7,178 New
7,178 $207,000

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $819M
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track Creative Planning Portfolio

Follow Creative Planning and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.